Keiji Yasukawa Selected Research

Squamous Cell Carcinoma (Epidermoid Carcinoma)

9/2014

In vivo imaging of tumor physiological, metabolic, and redox changes in response to the anti-angiogenic agent sunitinib: longitudinal assessment to identify transient vascular renormalization.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Keiji Yasukawa Research Topics

Disease

7	Stomach Ulcer (Gastric Ulcer) 01/2022 - 02/2004
6	Colitis 01/2020 - 05/2009
4	Ulcer 01/2022 - 04/2006
4	Ulcerative Colitis 01/2020 - 12/2012
2	Inflammation (Inflammations) 01/2018 - 12/2015
2	Hypertension (High Blood Pressure) 11/2013 - 01/2012
2	Stroke (Strokes) 01/2012 - 12/2009
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Neoplasms (Cancer) 09/2014
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2014
1	Heart Failure 11/2013
1	Fibrosis (Cirrhosis) 11/2013
1	Left Ventricular Dysfunction 11/2013
1	Rheumatoid Arthritis 11/2011
1	Experimental Arthritis 11/2011
1	Schizophrenia (Dementia Praecox) 07/2011
1	Reperfusion Injury 03/2009

Drug/Important Bio-Agent (IBA)

7	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 02/2004
6	nitroxylIBA 01/2022 - 02/2004
5	Dextrans (Dextran)FDA Link 01/2020 - 05/2009
4	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2020 - 12/2012
4	Indomethacin (Indometacin)FDA LinkGeneric 01/2020 - 04/2006
3	Toll-Like Receptor 4IBA 01/2020 - 09/2014
3	Oxygen (Dioxygen)IBA 01/2019 - 09/2014
3	Drinking WaterIBA 01/2019 - 05/2009
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018 - 12/2012
2	Protein Tyrosine PhosphatasesIBA 01/2020 - 01/2018
2	3-nitrotyrosineIBA 01/2018 - 09/2014
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 09/2014
2	Biomarkers (Surrogate Marker)IBA 12/2015 - 09/2014
2	Peroxidase (Myeloperoxidase)IBA 12/2015 - 12/2012
2	P-SelectinIBA 09/2014 - 12/2012
2	pimagedine (aminoguanidine)IBA 09/2014 - 12/2012
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 09/2014 - 12/2012
2	olmesartanIBA 01/2012 - 12/2009
2	AntioxidantsIBA 01/2012 - 07/2011
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2020
1	NitrogenIBA 01/2019
1	MCPROXYLIBA 01/2019
1	Streptozocin (Streptozotocin)FDA Link 01/2019
1	tempolIBA 01/2019
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 01/2019
1	Dextran SulfateIBA 01/2018
1	LipopolysaccharidesIBA 01/2018
1	Tyrosine (L-Tyrosine)FDA Link 01/2018
1	Bupivacaine (Bupivacaine Hydrochloride)FDA LinkGeneric 12/2015
1	Angiogenesis InhibitorsIBA 09/2014
1	Tyrosine Kinase InhibitorsIBA 09/2014
1	Sunitinib (Sutent)FDA Link 09/2014
1	Lactic Acid (Lactate)FDA LinkGeneric 09/2014
1	Pyruvic Acid (Pyruvate)IBA 09/2014
1	1,3- dihydroxy- 4,4,5,5- tetramethyl- 2- (4- carboxyphenyl)tetrahydroimidazole (NOR 1)IBA 09/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2014
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 11/2013
1	SympatholyticsIBA 11/2013
1	Collagen Type I (Type I Collagen)IBA 11/2013
1	moxonidine (Moxon)IBA 11/2013
1	Indicators and Reagents (Reagents)IBA 11/2013
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 12/2012
1	Nitric Oxide Synthase (NO Synthase)IBA 12/2012
1	2- phenyl- 4,4,5,5- tetramethylimidazoline- 1- oxyl- 3- oxideIBA 12/2012
1	candesartanIBA 01/2012
1	Angiotensin Receptor AntagonistsIBA 01/2012
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2012
1	azelnidipineIBA 01/2012
1	Amlodipine (Norvasc)FDA LinkGeneric 01/2012
1	Analgesics (Analgesic Drugs)IBA 11/2011
1	Aripiprazole (Abilify)FDA Link 07/2011
1	Type 1 Angiotensin ReceptorIBA 12/2009
1	SodiumIBA 05/2009
1	TEMPOIBA 04/2006
1	Pharmaceutical PreparationsIBA 04/2006
1	hydroxide ionIBA 02/2004

Therapy/Procedure

2	Therapeutics 09/2014 - 01/2012
1	Precision Medicine 01/2022